Taking the right chances
Regulatory reach is extending further, the price we might have to pay for growth is higher than ever and, economically, we’re still on uncertain ground. Is it all worth the risk?
adapt and evolve
Risk, as we once knew it, has changed. When a crisis hits, the pressure to respond is enormous. Companies need to be prepared.
We need to address Europe’s failing economic policy, argue Alistair Darling and Peter Bofinger.
By the end of 2015, US M&A deal value reached US$1.98 trillion—surpassing the previous record set in the pre-crisis days of 2006
US M&A market on a high
Overall M&A value surged in 2015, driven by megadeals—some of the biggest the market has ever seen
Three sectors dominated US M&A in 2015: technology, industrials and pharmaceuticals, medical and biotechnology (PMB)
The US M&A market in figures
Infographic: Charting the latest trends
Private equity in focus
Buyout value surged to US$122.68 billion in H2 2015, up almost US$40 billion compared to H2 2014. Yet buyout volume dipped 15% over the same period
Has leverage reached its limits?
Leveraged lending guidelines have contributed to the relative decline in private equity M&A in the US
With 2015 behind us, dealmakers should be aware of the potential risks and trends that lie ahead
“During the crisis, everybody was looking at emerging markets, but now the US is looking like a good place to put money, as the underlying economy looks pretty stable.”
John Reiss, Global Head of M&A, White & Case
Record breaker: US M&A in 2015
With confidence soaring, deal value in the United States hit new heights